articleTop 1% cited

Derivation of the sledai. A disease activity index for lupus patients

Arthritis & Rheumatism · 1992 · Vol. 35(6) · pp. 630–640

Claire Bombardier✉(Wellesley Institute)Dafna D. Gladman(Wellesley Institute)Murray B. Urowitz(Wellesley Institute)Dominique Caron(Wellesley Institute)Chi Hsing Chang(Wellesley Institute)Alex Austin(Wellesley Institute)Alan Bell(Wellesley Institute)D. Blöch(Wellesley Institute)Paul Corey(Wellesley Institute)John L. Decker(Wellesley Institute)John M. Esdaile(Wellesley Institute)James F. Fries(Wellesley Institute)Ellen M. Ginzler(Wellesley Institute)Charles H. Goldsmith(Wellesley Institute)Marc C. Hochberg(Wellesley Institute)John Verrier Jones(Wellesley Institute)Nicole G.H. Le Riche(Wellesley Institute)Matthew H. Liang(Wellesley Institute)Michael D. Lockshin(Wellesley Institute)Larry R. Muenz(Wellesley Institute)David L. Sackett(Wellesley Institute)Peter H. Schur(Wellesley Institute)

View via DOI Publisher page

Abstract

The SLEDAI is a validated model of experienced clinicians' global assessments of disease activity in lupus. It represents the consensus of a group of experts in the field of lupus research.

Systemic Lupus Erythematosus Research Atherosclerosis and Cardiovascular Diseases Rheumatoid Arthritis Research and TherapiesMedicineDiseaseRating scaleSystemic lupus erythematosusRegression analysisInternal medicinePhysical therapyIndex (typography)StatisticsMathematics

MeSH terms

Central Nervous SystemHumansImmune SystemIndividualityKidneyLupus Erythematosus, SystemicMusculoskeletal SystemSeverity of Illness IndexSkinVasculitisReproducibility of Results

Citations

4,551

FWCI

24.67

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus